Diagnostic and Prognostic Value of Circulating MicroRNAs for Esophageal Squamous Cell Carcinoma: a Systematic Review and Meta-analysis.

作者: Can Yao , Hai-Ning Liu , Hao Wu , Yan-Jie Chen , Yu Li

DOI: 10.7150/JCA.25351

关键词:

摘要: Background and Aim: MicroRNAs, dysregulated in the circulation of esophageal squamous cell carcinoma (ESCC) patient, have been assumed to be with great potential diagnosis prognosis cancer. We aimed review previous articles on ESCC. Methods: A search electronic databases was performed before Nov 12, 2017. summarized identification microRNA imbalance blood ESCC compared healthy controls, objective evaluate efficiency microRNAs diagnosing forecasting Results: total 35 studies investigating plasma or serum were included meta-analysis. Based consequences quality assessment each study, involved appropriate for quantitative synthesis. For diagnostic The overall pooled sensitivity, specificity, area under curve circulating is 0.794 (95% CI: 0.765 - 0.820), 0.779 (95%CI: 0.746 0.808), 0.86 0.82 0.88). value calculated respectively. prognostic meta-analysis, hazard ratios higher expression 1.34 1.14-1.58), which could significantly predict poorer survival Conclusions: Circulating distinguish patients from controls high sensitivity other invasive currently used screening methods. Simultaneously, there

参考文章(57)
A Porzionato, V Guzzardo, V Macchi, R De Caro, A Parenti, G Fassina, V Ninfo, S Pizzi, Expression pattern of squamous cell carcinoma antigen in oesophageal dysplasia and squamous cell carcinoma. Histology and Histopathology. ,vol. 22, pp. 989- 995 ,(2007) , 10.14670/HH-22.989
Ze-Liang Shi, Shen Fu, Ping Li, Bing-Xin Li, Qi Yu, Circulating microRNAs in esophageal squamous cell carcinoma: association with locoregional staging and survival. International Journal of Clinical and Experimental Medicine. ,vol. 8, pp. 7241- 7250 ,(2015)
Zhaojing Jiang, Qiancheng Song, Suoping Yang, Rong Zeng, Xufeng Li, Chunyu Jiang, Weimin Ding, Jiren Zhang, Yanfang Zheng, Serum microRNA-218 is a potential biomarker for esophageal cancer Cancer Biomarkers. ,vol. 15, pp. 381- 389 ,(2015) , 10.3233/CBM-150480
J. Wan, W. Wu, Y. Che, N. Kang, R. Zhang, Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer. Diseases of The Esophagus. ,vol. 29, pp. 412- 420 ,(2016) , 10.1111/DOTE.12338
O. YILMAZ, A. EROGLU, E. DAG, N. KARAOGLANOGLU, A. YILMAZ, Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer. International Journal of Clinical Practice. ,vol. 60, pp. 1604- 1608 ,(2006) , 10.1111/J.1742-1241.2006.00854.X
Tad Kim, Stephen R Grobmyer, Reshelle Smith, Kfir Ben-David, Darwin Ang, Stephen B Vogel, Steven N Hochwald, Esophageal cancer--the five year survivors. Journal of Surgical Oncology. ,vol. 103, pp. 179- 183 ,(2011) , 10.1002/JSO.21784
Shanghui Guan, Cong Wang, Xuan Chen, Bowen Liu, Bingxu Tan, Fang Liu, Ding Wang, Lihui Han, Lu Wang, Xiaochen Huang, Jiangfeng Wang, Bin Yao, Jialei Shi, Pengxiang Chen, Effat Un Nesa, Qingxu Song, Yufeng Cheng, MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma Tumor Biology. ,vol. 37, pp. 4383- 4391 ,(2016) , 10.1007/S13277-015-4271-8
Colin B. Begg, Madhuchhanda Mazumdar, Operating characteristics of a rank correlation test for publication bias. Biometrics. ,vol. 50, pp. 1088- 1101 ,(1994) , 10.2307/2533446
W. DONG, B. LI, Z. WANG, Z. ZHANG, J. WANG, Clinical significance of microRNA-24 expression in esophageal squamous cell carcinoma. Neoplasma. ,vol. 62, pp. 250- 258 ,(2015) , 10.4149/NEO_2015_030
Yuji Tachimori, Norio Kanamori, Norihisa Uemura, Norikazu Hokamura, Hiroyasu Igaki, Hoichi Kato, Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma The Journal of Thoracic and Cardiovascular Surgery. ,vol. 137, pp. 49- 54 ,(2009) , 10.1016/J.JTCVS.2008.05.016